Scorbolamide 300 mg + 100 mg + 5 mg, 40 coated tablets

Fever and pain associated with colds or flu, headaches, neuralgia.

Each coated tablet contains: 300 mg of salicylamide ( Salicylamidum ), 100 mg of ascorbic acid ( Acidum ascorbicum ), 5 mg of rutoside ( Rutosidum ).

Excipients with known effect : sucrose and quinoline yellow (E104).

Scorbolamid contains:

• Salicylamide – has antipyretic, analgesic and anti-inflammatory effects.
• Rutoside – strengthens blood vessels and increases their elasticity. In addition, it protects vitamin C from oxidation and therefore vitamin C works longer.
• Ascorbic acid (vitamin C) – replenishes the deficiency of vitamin C, supporting the body’s immunity during infections.

Adults and adolescents over 16 years of age:

Orally, usually 1 to 2 coated tablets 3 times a day.

The product is best taken with a meal or a glass of water or milk.

The lowest effective doses should be used. Symptomatic treatment without medical advice should be as short as possible.

-hypersensitivity to the active substances or any of the excipients;

-hypersensitivity to other nonsteroidal anti-inflammatory drugs;

– asthma with nasal polyps (induced or exacerbated by acetylsalicylic acid);

– active gastric and duodenal ulcers, inflammatory conditions of the gastrointestinal tract;

-acid-base balance disorders (diabetes, uremia, tetany);

– blood clotting disorders (e.g. hemophilia, thrombocytopenia);

– genetically determined glucose-6-phosphate dehydrogenase deficiency (risk of hemolysis after long-term oral administration of ascorbic acid);

– history of nephrolithiasis (risk of urinary stone formation after administration of high doses of ascorbic acid);

-hemochromatosis, sideroblastic anemia, excessive amounts of uric acid in the blood or oxalates in the urine; 

-pregnancy;

-breast-feeding.

The product should not be used in children under 16 years of age, except for rare diseases such as Kawasaki disease, due to the risk of Reye’s syndrome.